Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jun 26, 2021; 9(18): 4559-4572
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4559
Figure 4
Figure 4 Summary of the study (patients' stratification according to the newly proposed scoring systems: “6 and 12” and “Pre-TACE-Predict”). TACE: Transarterial chemoembolization; PS: Performance status; PVT: Portal vein thrombosis; EHS: Extra-hepatic spread; “6&12”: “Six-and-Twelve”; cTACE: Conventional transarterial chemoembolization; OS: Overall survival; ICIs: Immune checkpoint inhibitors.

  • Citation: Adhoute X, Larrey E, Anty R, Chevallier P, Penaranda G, Tran A, Bronowicki JP, Raoul JL, Castellani P, Perrier H, Bayle O, Monnet O, Pol B, Bourliere M. Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results. World J Clin Cases 2021; 9(18): 4559-4572
  • URL: https://www.wjgnet.com/2307-8960/full/v9/i18/4559.htm
  • DOI: https://dx.doi.org/10.12998/wjcc.v9.i18.4559